Literature DB >> 12512912

Dendritic cells highly quoted on immunotherapy stock market.

Giuseppe Masucci.   

Abstract

Mesh：

Year:  2002        PMID： 12512912     DOI： 10.1385/MO:19:4:195

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  2 in total

1.  Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma.

Authors:  M Bendandi; C D Gocke; C B Kobrin; F A Benko; L A Sternas; R Pennington; T M Watson; C W Reynolds; B L Gause; P L Duffey; E S Jaffe; S P Creekmore; D L Longo; L W Kwak
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

Review 2.  Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

Authors:  Giorgio Parmiani; Chiara Castelli; Piero Dalerba; Roberta Mortarini; Licia Rivoltini; Francesco M Marincola; Andrea Anichini
Journal:  J Natl Cancer Inst       Date:  2002-06-05       Impact factor: 13.506
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.